Drug Type Nanobody, Bispecific antibody |
Synonyms HuNbTROP2-HSA |
Target |
Action inhibitors, modulators |
Mechanism Trop-2 inhibitors(Tumor-associated calcium signal transducer 2 inhibitors), albumin modulators(Serum albumin modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pancreatic Cancer | Preclinical | China | - |






